In the present study, we measured the expression levels of Beclin 1 and Bcl-xL by Western blotting and immunohistochemistry (IHC) in human epithelial ovarian tumors with normal ovarian tissues as controls. The gene discussed is BCL2L1; the disease is ovarian epithelial tumor.